Cargando…

Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy

PURPOSE: Diabetic foot ulcers (DFU) are severe complications of diabetes, posing significant health and societal challenges. Elevated levels of reactive oxygen species (ROS) at the ulcer site hinder wound healing in most patients, while individuals with diabetes are also more susceptible to bacteria...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xiaofei, Shi, Lihua, Lin, Yin, Zhang, Cong, Liu, Penghui, Zhang, Ran, Chen, Qiqi, Ouyang, Xudong, Gao, Yuanyuan, Wang, Yingshuai, Sun, Tongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614664/
https://www.ncbi.nlm.nih.gov/pubmed/37908670
http://dx.doi.org/10.2147/IJN.S427055
_version_ 1785129068894617600
author Huang, Xiaofei
Shi, Lihua
Lin, Yin
Zhang, Cong
Liu, Penghui
Zhang, Ran
Chen, Qiqi
Ouyang, Xudong
Gao, Yuanyuan
Wang, Yingshuai
Sun, Tongyi
author_facet Huang, Xiaofei
Shi, Lihua
Lin, Yin
Zhang, Cong
Liu, Penghui
Zhang, Ran
Chen, Qiqi
Ouyang, Xudong
Gao, Yuanyuan
Wang, Yingshuai
Sun, Tongyi
author_sort Huang, Xiaofei
collection PubMed
description PURPOSE: Diabetic foot ulcers (DFU) are severe complications of diabetes, posing significant health and societal challenges. Elevated levels of reactive oxygen species (ROS) at the ulcer site hinder wound healing in most patients, while individuals with diabetes are also more susceptible to bacterial infections. This study aims to synthesize a comprehensive therapeutic material using polysaccharides from Pycnoporus sanguineus to promote DFU wound healing, reduce ROS levels, and minimize bacterial infections. METHODS: Polysaccharides from P.sanguineus were employed as reducing and stabilizing agents to fabricate polysaccharide-based composite particles (PCPs) utilizing silver ions as templates. PCPs were characterized via UV-Vis, TEM, FTIR, XRD, and DLS. The antioxidant, antimicrobial, and cytotoxic properties of PCPs were assessed through in vitro and cellular experiments. The effects and mechanisms of PCPs on wound healing were evaluated using a diabetic ulcer mouse model. RESULTS: PCPs exhibited spherical particles with an average size of 57.29±22.41 nm and effectively combined polysaccharides’ antioxidant capacity with silver nanoparticles’ antimicrobial function, showcasing synergistic therapeutic effects. In vitro and cellular experiments demonstrated that PCPs reduced cellular ROS levels by 54% at a concentration of 31.25 μg/mL and displayed potent antibacterial activity at 8 μg/mL. In vivo experiments revealed that PCPs enhanced the activities of superoxide dismutase (SOD) and catalase (CAT), promoting wound healing in DFUs and lowering the risk of bacterial infections. CONCLUSION: The synthesized PCPs offer a novel strategy for the comprehensive treatment of DFU. By integrating antioxidant and antimicrobial functions, PCPs effectively promote wound healing and alleviate patient suffering. The present study demonstrates a new strategy for the integrated treatment of diabetic wounds and expands the way for developing and applying the polysaccharide properties of P. sanguineus.
format Online
Article
Text
id pubmed-10614664
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106146642023-10-31 Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy Huang, Xiaofei Shi, Lihua Lin, Yin Zhang, Cong Liu, Penghui Zhang, Ran Chen, Qiqi Ouyang, Xudong Gao, Yuanyuan Wang, Yingshuai Sun, Tongyi Int J Nanomedicine Original Research PURPOSE: Diabetic foot ulcers (DFU) are severe complications of diabetes, posing significant health and societal challenges. Elevated levels of reactive oxygen species (ROS) at the ulcer site hinder wound healing in most patients, while individuals with diabetes are also more susceptible to bacterial infections. This study aims to synthesize a comprehensive therapeutic material using polysaccharides from Pycnoporus sanguineus to promote DFU wound healing, reduce ROS levels, and minimize bacterial infections. METHODS: Polysaccharides from P.sanguineus were employed as reducing and stabilizing agents to fabricate polysaccharide-based composite particles (PCPs) utilizing silver ions as templates. PCPs were characterized via UV-Vis, TEM, FTIR, XRD, and DLS. The antioxidant, antimicrobial, and cytotoxic properties of PCPs were assessed through in vitro and cellular experiments. The effects and mechanisms of PCPs on wound healing were evaluated using a diabetic ulcer mouse model. RESULTS: PCPs exhibited spherical particles with an average size of 57.29±22.41 nm and effectively combined polysaccharides’ antioxidant capacity with silver nanoparticles’ antimicrobial function, showcasing synergistic therapeutic effects. In vitro and cellular experiments demonstrated that PCPs reduced cellular ROS levels by 54% at a concentration of 31.25 μg/mL and displayed potent antibacterial activity at 8 μg/mL. In vivo experiments revealed that PCPs enhanced the activities of superoxide dismutase (SOD) and catalase (CAT), promoting wound healing in DFUs and lowering the risk of bacterial infections. CONCLUSION: The synthesized PCPs offer a novel strategy for the comprehensive treatment of DFU. By integrating antioxidant and antimicrobial functions, PCPs effectively promote wound healing and alleviate patient suffering. The present study demonstrates a new strategy for the integrated treatment of diabetic wounds and expands the way for developing and applying the polysaccharide properties of P. sanguineus. Dove 2023-10-26 /pmc/articles/PMC10614664/ /pubmed/37908670 http://dx.doi.org/10.2147/IJN.S427055 Text en © 2023 Huang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Huang, Xiaofei
Shi, Lihua
Lin, Yin
Zhang, Cong
Liu, Penghui
Zhang, Ran
Chen, Qiqi
Ouyang, Xudong
Gao, Yuanyuan
Wang, Yingshuai
Sun, Tongyi
Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy
title Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy
title_full Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy
title_fullStr Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy
title_full_unstemmed Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy
title_short Pycnoporus sanguineus Polysaccharides as Reducing Agents: Self-Assembled Composite Nanoparticles for Integrative Diabetic Wound Therapy
title_sort pycnoporus sanguineus polysaccharides as reducing agents: self-assembled composite nanoparticles for integrative diabetic wound therapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614664/
https://www.ncbi.nlm.nih.gov/pubmed/37908670
http://dx.doi.org/10.2147/IJN.S427055
work_keys_str_mv AT huangxiaofei pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy
AT shilihua pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy
AT linyin pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy
AT zhangcong pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy
AT liupenghui pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy
AT zhangran pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy
AT chenqiqi pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy
AT ouyangxudong pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy
AT gaoyuanyuan pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy
AT wangyingshuai pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy
AT suntongyi pycnoporussanguineuspolysaccharidesasreducingagentsselfassembledcompositenanoparticlesforintegrativediabeticwoundtherapy